Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770518 | SCV000901964 | uncertain significance | Cardiomyopathy | 2016-01-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000770518 | SCV001344010 | likely benign | Cardiomyopathy | 2019-10-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001426915 | SCV001629576 | likely benign | Hypertrophic cardiomyopathy | 2024-11-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001426915 | SCV004815464 | likely benign | Hypertrophic cardiomyopathy | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004678821 | SCV005178976 | likely benign | Cardiovascular phenotype | 2024-04-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724150 | SCV001957249 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001724150 | SCV001975109 | likely benign | not provided | no assertion criteria provided | clinical testing |